Delivery Order SPE2DB24D2012-SPE2DB26FBUNJ
- Not listed
- The Defense Logistics Agency awarded a $3,978.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 31, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 0.25 mg tablets (60-count unit) with a ceiling value of $10,068.17. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a $17,318.52 delivery order to AmerisourceBergen Drug Corp for Everolimus 1 mg tablets (60 count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count) under a firm fixed-price contract valued at $10,949.64. This delivery order, which is a child award under AmerisourceBergen's broader contract vehicle, represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (quantity: 30 count) under a firm fixed price contract valued at $18,147.63, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award represents a single delivery order fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Everolimus 5 mg tablets (30-count packages) with a ceiling value of $44,765.09. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Everolimus 10 mg tablets in unit dose packaging (28 count). This is a firm fixed-price delivery order with a ceiling value of $1,358.26 and an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Everolimus 10 mg tablets (unit dose, 28-count packages) with a ceiling value of $1,358.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Everolimus 5 mg tablets in quantities of 30 units, with a ceiling value of $19,375.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion on July 23, 2025, with performance being executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Everolimus 0.75 mg tablets (60-count units) with a contract value of $7,139.43. This firm fixed-price delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competed delivery order under AmerisourceBergen's existing contract vehicle with the...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB26FBUNJDelivery Order
The Defense Logistics Agency awarded a $2,972.74 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Everolimus 1 mg tablets (60 count). This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-compete, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The contract reflects AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/20/25 |